CELLTRION PORTUGAL, UNIPESSOAL LDA secures contract for Infliximab 100 Mg Biosimilar Remsima Powder Conc Sol Inj Fr Iv

Portugal, April 7 -- Portugal based CELLTRION PORTUGAL, UNIPESSOAL LDA has secured contract from Unidade Local De Saude De Almada-Seixal, E.P.E. for Infliximab 100 Mg Biosimilar Remsima Powder Conc Sol Inj Fr Iv. The value of the contract is worth 10805200 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....